![]() | Up a level |
Edinoff, Amber N and Fort, Juliana M and Singh, Christina and Wagner, Sarah E and Rodriguez, Jessica R and Johnson, Catherine A and Cornett, Elyse M and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2022) Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurology International , 14 , (2) , pp. 423-436.
Gribben, Andrew and Burke, Tara and Harrington, Colm and Husein, Amanda and Murnane, Kevin S and Hendricks, Peter S and Tobin, Katy and Ivers, Jo-Hanna and Thuery, Guillaume and Harkin, Andrew and Kelly, John R (2024) Amid magic and menace: psychiatrists' attitudes to psilocybin therapy. Irish Journal of Psychological Medicine , 41 , (4) , pp. 451-459.
Edinoff, Amber N and Nix, Catherine A and Orellana, Claudia V and StPierre, Samantha M and Crane, Erin A and Bulloch, Blaine T and Cornett, Elyse M and Kozinn, Rachel L and Kaye, Adam M and Murnane, Kevin S and Kaye, Alan D (2021) Naltrexone implant for opioid use disorder. Neurology International , 14 , (1) , pp. 49-61.
Murnane, Kevin S and Edinoff, Amber N and Cornett, Elyse M and Kaye, Alan D (2023) Updated perspectives on the neurobiology of substance use disorders using neuroimaging. Substance Abuse and Rehabilitation , 14 , pp. 99-111.
Edinoff, Amber N and Sall, Saveen and Upshaw, William C and Spillers, Noah J and Vincik, LeighAnn Y and De Witt, Adalyn S and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2024) Xylazine: a drug adulterant of clinical concern. Current Pain and Headache Reports , 28 , pp. 417-426.